Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Indocid Capsules 25 mg.
| Pharmaceutical Form |
|---|
|
Indocid Capsules 25 mg are ivory, opaque capsules marked ‘MSD 25’. |
Indocid Capsules 25 mg contain 25 mg of indometacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Indometacin |
Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase. |
| List of Excipients |
|---|
|
Colloidal silicon dioxide Capsule shells: Gelatin |
Indometacin Capsules 25 mg: high density bottles with high density polyethylene cap-to-cap closures containing 100 or 500 capsules. Opaque 250 micron PVC blisters with 20 micron aluminium lid. Each blister contains 10 capsules. Each pack contains 90 capsules.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PL 39699/012
Date of first authorisation: 12 June 1981
| Drug | Countries | |
|---|---|---|
| INDOCID | Austria, Australia, Brazil, Estonia, France, Hong Kong, Mexico, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
